{
    "code": 0,
    "data": [
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 & 9M FY26 Earning Conference Call Transcript",
            "news_id": "b05c5b37-a7e4-48f5-a671-278180290709",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12526510-623f-4c1d-8698-a5cd5f755758.pdf",
            "news_date": "2026-02-10 20:46:38",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY26 Investor Presentation",
            "news_id": "e1725ad3-e131-48b4-857e-71beff7cf44a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a8d8db7-2785-4ce0-82c9-154468f69abb.pdf",
            "news_date": "2026-02-03 20:01:47",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financials Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "51164847-41e2-4fcc-9a1e-12c9bfec351f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06b881ec-e0b0-44db-a760-96791d3a1c50.pdf",
            "news_date": "2026-02-03 18:55:59",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 & H1 FY26 Earning Conference Call Transcript",
            "news_id": "92538321-f770-44f8-aec9-a77977733332",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1be6f5fc-e6b7-4807-832c-63ac97f90a7d.pdf",
            "news_date": "2025-11-14 18:46:33",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 and H1 FY 26 Investor Presentation",
            "news_id": "81abe44e-ba0c-43ad-98b2-208c0616aed4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2f24fc5-1403-4507-8511-5a45fb18ff06.pdf",
            "news_date": "2025-11-07 20:45:13",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "77690fd1-fd9b-407e-9e37-acc52fe7f837",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0706d35f-c912-49aa-a306-222baa4dc32f.pdf",
            "news_date": "2025-11-07 14:48:30",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached presentation made to the shareholders at 40th AGM",
            "news_id": "28b1d18a-747f-40a1-81d1-5e0fce7b01d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8408530c-9a97-4c86-85e6-fe7ffbfdb4e9.pdf",
            "news_date": "2025-09-24 20:35:14",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY26 Earning Conference Call",
            "news_id": "c25661e9-e5bd-4153-bd4c-acc1cd139c1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=713d4b40-7c37-46a7-8a00-3cbb42308964.pdf",
            "news_date": "2025-07-25 23:04:56",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1FY26 Investor Presentation",
            "news_id": "e65d58ee-b99e-4e76-aba3-8de230809dc8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31508af2-3857-41d0-87c6-11cc757f16df.pdf",
            "news_date": "2025-07-19 18:08:56",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the quarter ended June 30 2025",
            "news_id": "b84f716e-98ce-4d0a-a073-31e4d76f2c08",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d21b39c-a847-4d03-a99c-732102d5beb2.pdf",
            "news_date": "2025-07-18 16:40:52",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4FY25 Earning concall transcript",
            "news_id": "303b7f83-d9ae-4e4f-a7ea-15e269371536",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=617079fa-ec10-423d-9928-f7d3d1819bf9.pdf",
            "news_date": "2025-05-12 23:59:55",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4 & FY25 Investor Presentation",
            "news_id": "97595396-9e53-42b8-b00a-8d651c9653e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b0903a9-7c4f-4bd6-aa65-ad7f91519bc7.pdf",
            "news_date": "2025-05-06 18:59:57",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting And Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Outcome of the Board meeting and Financial Results for the quarter and year ended March 31 2025",
            "news_id": "a5c2fa1b-5c01-4e81-82b0-f0b1339101b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cbe7063-7486-4b1f-b49a-bef6526dce95.pdf",
            "news_date": "2025-05-06 16:23:54",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY25 Earnings call transcript",
            "news_id": "142a8fe9-f68c-4be4-9b2e-238a8b742c2d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43f4aa71-65b7-489e-9d31-e79810448d7f.pdf",
            "news_date": "2025-02-04 22:25:45",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY25 Investor Presentation",
            "news_id": "c6c547fe-79d9-41e7-b0f2-ae54e4a84bae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66ba3057-031b-4784-ab65-4476425adc62.pdf",
            "news_date": "2025-01-29 21:13:59",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim Dividend",
            "news_body": "Financial Resuls for the quarter and nine months ended December 31 2024 and Interim dividend",
            "news_id": "3ee3460d-19fb-4982-bc18-bb3ef5fad5a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7fc2977-e25b-4eb8-8841-a3d69eb72274.pdf",
            "news_date": "2025-01-29 16:41:14",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2FY25 Earning call",
            "news_id": "86118c0f-5505-4347-9bd7-47c1154f7eb1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fdf1955-f801-4102-86fd-a76096a0ec66.pdf",
            "news_date": "2024-11-02 19:10:29",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 and FY25 Investor Presentation",
            "news_id": "ddfc64e4-f70a-488a-b46e-8322bd6718c3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cd31747-68a5-4f62-9b2b-5ef3e68208d1.pdf",
            "news_date": "2024-10-24 21:28:51",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "b9732165-72d9-4be2-b4b2-ff412e09ee4c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83654e8a-1c51-4d42-9686-09692520120d.pdf",
            "news_date": "2024-10-24 18:04:42",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation made to the shareholders at the 39th AGM",
            "news_id": "ed5c2ab8-6da8-4409-a04e-c59cc6e181f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abdd4481-cae9-423f-8863-9ba3db07a974.pdf",
            "news_date": "2024-09-20 19:56:00",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY25 earning conference call",
            "news_id": "3f3fc2e5-632a-4a8c-ad83-87032d5439be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d8f4ed0-30e9-42c7-85e2-fd8c3aa1ef5b.pdf",
            "news_date": "2024-08-05 18:14:35",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1FY25 Investor Presentation",
            "news_id": "ff8adb6f-2e9a-44f5-81cd-7f5d96f9ef2c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=042a25ed-6198-4627-9438-0f308a6829f3.pdf",
            "news_date": "2024-07-26 19:32:17",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Financial Results for the quarter ended June 30, 2024",
            "news_id": "c464a17c-6116-4278-a166-75dcadec2e98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d742fc3c-a4ca-400b-81b8-2f9d2ea5284f.pdf",
            "news_date": "2024-07-26 17:34:33",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY 24 earning call transcript.",
            "news_id": "16ca7d34-b374-4109-bb2e-5c3a345ecb95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be128bae-e8ea-4eb9-9074-e07afaf24f88.pdf",
            "news_date": "2024-05-10 19:59:01",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quater and Year ended March 31, 2024.",
            "news_id": "cfab4070-77e4-4048-aa75-df1b2d157ee7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38b37233-9605-4055-a607-f93fc9fc1d2a.pdf",
            "news_date": "2024-05-04 18:17:43",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "Financial Results for the quarter and year ended March 31, 2024",
            "news_id": "bca9021e-503e-4784-afec-4b29457dac62",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=114f388a-8088-41a1-8583-04981eed3038.pdf",
            "news_date": "2024-05-03 16:37:33",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call transcript",
            "news_id": "ac7aa5df-0985-4e10-8be3-f5785edf52f3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=809936e1-5c06-4b69-903a-f870d0754cf9.pdf",
            "news_date": "2024-02-01 19:09:18",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY24 Investor Presentation",
            "news_id": "dbe03b77-80a1-48b5-8be7-73e8a51d941d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e26594e4-af29-4245-8233-c62c1004c943.pdf",
            "news_date": "2024-01-24 19:19:26",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023.",
            "news_body": "Audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2023",
            "news_id": "8788bed6-27fd-4724-8a5b-3fd90ca339f2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2ade16d-e9b5-47fd-b15e-24635ec4fdd4.pdf",
            "news_date": "2024-01-24 16:02:35",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earning call for Q2 & H1 FY24",
            "news_id": "8ed426b3-0302-4263-a51d-30f83975b62e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91d689bc-6948-4c14-bee3-a0f6bc0affb1.pdf",
            "news_date": "2023-10-27 21:29:40",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 & H1 FY24 Investor Presentation",
            "news_id": "4a75d9d7-f548-403c-90de-fb05c3552fba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01c84402-aa9b-4263-8cbe-5ef7a3deb822.pdf",
            "news_date": "2023-10-19 18:23:37",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Financial Results for the quarter and half year ended September 30, 2023",
            "news_id": "387559a5-e23a-4738-b529-b0848107dfd9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f81b5fd-115b-4a76-9098-f755c625d8a4.pdf",
            "news_date": "2023-10-19 16:00:17",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to the shareholders at the 38th Annual General Meeting",
            "news_id": "3663a061-64a1-418d-a5c5-66a97f79f1a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56c46cb6-18b8-46e9-a4a4-8cf689c836aa.pdf",
            "news_date": "2023-09-26 20:53:24",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY24 Earning Conference Call",
            "news_id": "9794b82e-d3f3-47f7-a218-757db0febd5b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01d281eb-7463-4082-836f-dc25cce40082.pdf",
            "news_date": "2023-07-28 20:40:57",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of earning call on the financial results for the quarter ended June 30, 2023",
            "news_id": "8cec73e1-722d-4134-a393-cb56ae41db26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c47b8c67-c16a-4f8f-bf6a-9ed33d3d1fe4.pdf",
            "news_date": "2023-07-24 21:32:37",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q1FY24 Investor Presentation",
            "news_id": "84b8d1f2-a813-4752-9806-c33d1025ceef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d72a2a0-f6a0-4699-ab8c-1b69c2d930fa.pdf",
            "news_date": "2023-07-21 19:42:49",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Financial Results for the quarter ended June 30, 2023",
            "news_id": "61e2f693-06f3-429d-ad66-7e7dcb6a0233",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e7454c0-6860-4999-990c-91711231602b.pdf",
            "news_date": "2023-07-21 16:42:49",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4 FY23 Earning Conference Call",
            "news_id": "f7382ff2-611c-404c-87ad-16d32d8222fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=451054ed-52d2-4da1-b754-10992cb9d2b0.pdf",
            "news_date": "2023-05-07 23:23:04",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4FY23 Results presentation",
            "news_id": "cb620984-eec8-4a8b-888e-3c70ba318c9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52b86931-cda4-48e2-80ec-ef6a05448d5d.pdf",
            "news_date": "2023-05-02 11:22:23",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2023",
            "news_id": "78ab5201-94f5-43aa-bebb-e1fb8f7193b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51da8fbb-09eb-4309-a103-925f144bb886.pdf",
            "news_date": "2023-04-29 18:50:34",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q3FY23 Results presentation of the Company for your records.",
            "news_id": "24039f1c-46e8-4b04-a222-bd8fd248149a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de8b282b-30de-4494-8a47-ee392d53f560.pdf",
            "news_date": "2023-01-27 18:37:18",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2022.",
            "news_body": "Audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2022.",
            "news_id": "f5837ef5-ccde-48c5-bd0c-15fc40576b79",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbea37d2-4cca-4df8-b8ca-7026d3e5c4c1.pdf",
            "news_date": "2023-01-27 16:43:58",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Compliance under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "f396d0ce-1dc0-4258-b3b8-4dd290c0aae3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccac31db-acff-46b4-8062-36675ae8e280.pdf",
            "news_date": "2022-11-02 19:56:03",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q2FY23 Results presentation of the Company for your records.",
            "news_id": "b961e3d1-72a3-4989-a7c0-b6c46de96b32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=257c9cfe-2aab-4f53-a6cc-1e49a4aa0f2e.pdf",
            "news_date": "2022-10-20 20:41:25",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "Audited Financial Results for the Quarter and half Year ended September 30, 2022",
            "news_id": "ba5c067f-a334-4f96-b726-534e154853f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=869c8deb-bd20-4f39-9409-d16e10256823.pdf",
            "news_date": "2022-10-20 15:35:57",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith presentation made to the shareholders of the Company at the 37th Annual General Meeting held today i.e. August 4, 2022 for your records.",
            "news_id": "5851741b-bdce-46c5-bac8-fef7a91f9b45",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=453161b8-6171-4d14-8079-d4c8abe161a8.pdf",
            "news_date": "2022-08-04 19:59:55",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q1 FY23 Earning Conference call.",
            "news_id": "7780a4d8-f566-4e60-ac8a-128fd6e28c4c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ee1afeb-1b0e-4634-ae51-e79a810ac242.pdf",
            "news_date": "2022-08-03 23:04:39",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Recording Of Conference Call",
            "news_body": "In continuation to our letter dated July 22, 2022 regarding intimation of Investors/ Analyst conference call on the Financial Results of the Company for the quarter ended June 30, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company's website.",
            "news_id": "4a69ce70-6888-4d02-846f-ca37bfd2b304",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c270be0-688a-4f88-b2b0-49b23134c9e6.pdf",
            "news_date": "2022-07-28 21:17:20",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith revised Q4FY22 Results presentation of the Company for your records. Changes have been made in slide number 8, 9, 11 and 13.",
            "news_id": "c0c9e23a-adde-4e83-8f21-e39603d49e54",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e701036-9288-44a3-8902-ca81ab21cb0d.pdf",
            "news_date": "2022-06-07 18:15:17",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended March 31, 2022.",
            "news_id": "a96afd46-da0d-47e9-9280-b2ccd7f51a3b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7c9e74c-ec24-4f16-8442-f135a2d69df2.pdf",
            "news_date": "2022-05-24 19:24:30",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q4 FY22 Earning Conference call.",
            "news_id": "018ed899-25a5-4f02-97bc-34e0bc9bfe30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=823d8383-f59b-4c82-8031-617b76d2a19c.pdf",
            "news_date": "2022-05-16 20:33:46",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Recording Of Conference Call",
            "news_body": "In continuation to our letter dated May 5, 2022 regarding intimation of Investors/ Analyst conference call on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company's website. This can be accessed via the following link. Link: https://www.aartidrugs.co.in/concalls-transcript/",
            "news_id": "c6ca5207-5d6e-429d-a9ed-4926cd1b64bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21fff3a1-a063-4bc0-a322-3fdf0af29653.pdf",
            "news_date": "2022-05-10 20:00:29",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q4FY22 Results presentation of the Company for your records.",
            "news_id": "6add4d01-6ebe-4e43-8616-55184285ad3c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be1b7ec6-c9c8-49a2-b3bf-f14742a433d5.pdf",
            "news_date": "2022-05-09 19:44:41",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2022",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Monday, May 9, 2022, approved the Audited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Year ended March 31, 2022. In this regards we enclose;<BR> i. Statement showing the Financial Results (Standalone and Consolidated),<BR> ii. Statement of Assets and Liabilities (Standalone and Consolidated),<BR> iii. Cash Flow Statement (Standalone and Consolidated)<BR> iv. Auditor's Report on the Financial Results (Standalone and Consolidated),<BR> v. Declaration in respect of Audit reports with unmodified opinion for the Financial Year ended March 31, 2022<BR>",
            "news_id": "679d181a-bfee-4009-afdf-a712e77df495",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d80f3fb1-2869-4961-9340-511dd0071d33.pdf",
            "news_date": "2022-05-09 15:42:52",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q3 FY22 Earning Conference call.",
            "news_id": "668d427e-ebe4-44eb-9d06-161607bbc684",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d13cca0b-cf46-41fb-a8a6-f8f7176da2f1.pdf",
            "news_date": "2022-02-14 19:03:32",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q3FY22 Results presentation of the Company for your records.",
            "news_id": "b84b91c7-7cde-4835-8d3d-dfee5a4868ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ec63de6-80dd-451d-ba95-454edfd8b85e.pdf",
            "news_date": "2022-01-31 23:19:45",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2021.",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Monday, January 31, 2022, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2021.<BR> Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015 we enclose the following:-<BR>   Audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2021.<BR>   Auditor's Report on Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2021.",
            "news_id": "f00b8733-a1cb-4404-af02-094a4641dbc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9495b6b2-21ff-4e02-8d5d-ab10e92f593c.pdf",
            "news_date": "2022-01-31 15:12:40",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q2 FY22 Earning Conference Call.",
            "news_id": "32a9be63-319f-4bb0-8f59-d78b6c4eb903",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73d2a789-50e0-4e6d-be3c-e60a66d443b4.pdf",
            "news_date": "2021-11-15 20:36:06",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Results Presentation for the Quarter and half year ended September 30, 2021 for your records.",
            "news_id": "b04957cd-d1de-465a-bd7f-75099d7b2e8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8182644c-ab76-43a8-8361-97c72a757ec0.pdf",
            "news_date": "2021-10-27 21:23:36",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Wednesday, October 27, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021.<BR> Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015 we enclose the following:-<BR>   Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021.<BR>   Standalone and Consolidated Statement of Assets and Liabilities.<BR>   Standalone and Consolidated Cash Flow Statement. <BR>   Auditor's Report on Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021.<BR> <BR> Further, please note that the Company has already made necessary arrangement to publish the same in the Newspapers as required under the SEBI (LODR) Regulations, 2015.",
            "news_id": "1cae350d-7976-4be1-b4a8-4bf78e057306",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a908dbf-ff0a-483d-9f8b-b83389f62758.pdf",
            "news_date": "2021-10-27 15:50:34",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q1 FY22 Earning Conference Call.",
            "news_id": "159328c9-c816-437b-9021-3580d79861e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e01c29d-03e9-4d09-8fbd-5be8e1750297.pdf",
            "news_date": "2021-08-31 23:17:31",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Results Presentation for the Quarter ended June 30, 2021 for your records.",
            "news_id": "c38a9585-e557-428e-83ec-8c68d722a1fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7a6e1f2-8c8d-486e-8109-701db7890b58.pdf",
            "news_date": "2021-07-28 14:51:46",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Tuesday, July 27, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021.",
            "news_id": "b58f0b65-1b7f-46f6-98a6-89fc2f1aa21a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d345ba37-8d85-44c6-a080-d02affc7d027.pdf",
            "news_date": "2021-07-27 18:23:26",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For Half Year Ended March 31, 2021",
            "news_body": "In compliance with Regulation 23(9) of SEBI (LODR) Regulations, 2015 we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2021.",
            "news_id": "35d61276-f471-46f7-acaa-e01b5157d7a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bbec15d-e2c8-4681-b291-a35b73482414.pdf",
            "news_date": "2021-06-13 15:42:20",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q4 FY21 Earning Conference Call.",
            "news_id": "e9a5c6a7-0539-4060-af6c-a6235fcadb7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f27914f-33c1-45f9-891e-d89fc4caefe2.pdf",
            "news_date": "2021-06-09 13:58:30",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Results Presentation for the Quarter and year ended March 31, 2021 for your records.",
            "news_id": "95e869ae-e780-4683-8ce9-0d5d8507d592",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3956f80c-600b-4bd9-9f9f-c3539486b35c.pdf",
            "news_date": "2021-05-17 15:32:09",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2021",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Saturday, May 15, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2021",
            "news_id": "9645b94b-9ede-4813-bbcd-cc28e12bc274",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=021b9e6c-750d-4ed7-b76b-131b4e75c219.pdf",
            "news_date": "2021-05-15 14:47:04",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}